Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Female Reproductive Hormones and Biomarkers of Oxidative Stress in Genital Chlamydia Infection in Tubal Factor Infertility

Authors
1 Medical Lab., Science Department, College of Medical Sciences, University of Calabar, Calabar, Nigeria
2 Department of Chemical Pathology, University of Ibadan, Ibadan, Nigeria
3 Department of Veterinary Pathology, University of Ibadan, Ibadan, Nigeria
4 Unit of Molecular Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China
5 Department of Medical Microbiology & Parasitology, University of Ibadan, Ibadan, Nigeria
6 Department of Obstetrics and Gynaecology, University of Ibadan, Ibadan, Nigeria
Abstract
Background: Genital Chlamydia infection (GCI) and the associated pathologies have been implicated in tubal infertility. Though the actual pathologic mechanisms are still uncertain, oxidative stress and other factors have been implicated. The purpose of the study was to determine the possible contribution of female reproductive hormones and biomarkers of oxidative stress in genital Chlamydial infection to tubal occlusion. Methods: This prospective case control study was carried out by recruiting 150 age matched women grouped into infertile Chlamydia positive women (n=50), fertile Chlamydia positive women (n=50) and fertile Chlamydia negative women as controls (n=50). High vaginal swabs and endocervical swabs were collected for screening Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Treponema pallidum, Staphylococcus aureus, and Candida albicans. Sera were collected for estimation of Chlamydia trachomatis antibody, female reproductive hormones [Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), Oestradiol (E2), Progesterone (P4), Prolactin (PRL)] and biomarkers of oxidative stress [Total Antioxidant Capacity (TAC) and 8-hydroxyl-2-deoxyguanosine (8-OHdG)] by enzyme immunoassay (EIA). Data were analyzed using chi square, analysis of variance and LSD Post hoc to determine mean differences at p=0.05. Results: Among women with GCI, higher levels of LH and 8-OHdG were observed in infertile Chlamydia positive women compared to fertile Chlamydia positive women (p<0.05). Higher levels of LH and 8-OHdG and lower TAC levels were observed in infertile Chlamydia positive women compared to fertile Chlamydia negative controls (p<0.05). Conclusion: Mechanisms including oxidative DNA damage and reduced antioxidant capacity may be involved in the pathology of Chlamydia induced tubal damage.
Keywords

  1. Hafner LM, Pelzer ES, editors. Tubal damage, infertility and tubal ectopic pregnancy: chlamydia trachomatis and other microbial aetiologies. Open access publisher: InTech; 2011. 13 p. (Kamrava M, editor. Ectopic Pregnancy-Modern Diagnosis and Management; vol. 2).
  2. Den Hartog JE, Morre SA, Land JA. Chlamydia trachomatis associated tubal factor subfertility, immunogenetic factors and serological screening. Hum Reprod Update. 2006;12(6):719-30.
  3. Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction. 2008;135(6):739-49.
  4. Agarwal T, Gupta R, Dutta R, Srivastava P, Bhengraj AR, Salhan S, et al. Protective or pathogenic immune response to genital chlamydial infection in women-A possible role of cytokine secretion profile of cervical mucosal cells. J Clin Immunol. 2009;130(3):347-54.
  5. Beatty WL, Byrne GI, Morrison RP. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 1994;2(3):94-8.
  6. Pal S, Hui W, Peterson EM, de la Maza LM. Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection. J Med Microbiol. 1998;47(7):599-605.
  7. Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis. 2010;201 Suppl 2:S114-25.
  8. Igietseme JU, Uriri IM, Kumar SN, Ananaba GA, Ojior OO, Momodu IA, et al. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun. 1998;66(9):4030-5.
  9. Agrawal T, Vats V, Salhan S, Mittal A. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women. J Reprod Immunol. 2009;83(1-2):173-8.
  10. Ness RB, Smith KJ, Chang CC, Schisterman EF, Bass DC. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis. 2006;33(3):137-42.
  11. Abdul-Sater AA, Said-Sadier N, Lam VM, Singh B, Pettengill MA, Soares F, et al. Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1. J Biol Chem. 2010;285(53):41637-45.
  12. Chandra A, Surti N, Kesavan Sh Agarwal A. Significance of oxidative stress in human reproduction. Arch Med Sci. 2009;5(1A):S28-S42.
  13. Polak G, Koziol-Montewka M, Gogacz M, Blaszkowska I, Kotarski J. Total antioxidant status of peritoneal fluid in infertile women. Eur J Obstet Gynecol Reprod Biol. 2001;94(2):261-3.
  14. Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril. 2002;77(5):861-70.
  15. Harma M, Harma M, Kocyigit A, Demir N. Role of plasma nitric oxide in complete hydatidiform mole. Eur J Gynaecol Oncol. 2004;25(3):333-5.
  16. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28.
  17. Ray SD, Lam TS, Rotollo JA, Phadke S, Patel C, Dontabhaktuni A, et al. Oxidative stress is the master operator of drug and chemically-induced programmed and unprogrammed cell death: Implications of natural antioxidants in vivo. Biofactors. 2004;21(1-4):223-32.
  18. Agarwal A, Allamaneni SS. Role of free radicals in female reproductive diseases and assisted reproduction. Reprod Biomed Online. 2004;9(3):338-47.
  19. Agrawal T, Vats V, Wallace PK, Salhan S, Mittal A. Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection. Reprod Biol Endocrinol. 2008;6:46.
  20. Amirshahi A, Wan C, Beagley K, Latter J, Symonds I, Timms P. Modulation of the Chlamydia trachomatis in vitro transcriptome response by the sex hormones estradiol and progesterone. BMC Microbiol. 2011;11:150.
  21. Practice Committee of the American Society for Reproductive Medicine. Definition of "infertility". Fertil Steril. 2004;82 Suppl 1:S206.
  22. National Collaborating Centre for Women’s and Children’s Health (UK). Fertility: assessment and treatment for people with fertility problems. National Institute for Health and Clinical Excellence: Guidance; 2004 Feb.
  23. World Health Organization, Department of Reproductive Health and Research. Sexually transmitted and other reproductive tract infections: A guide to essential practice. Switzerland: WHO; 2005. 196 p.
  24. Schachter J. Sexually transmitted chlamydia trachomatis infection: management of the most common venereal disease. Postgrad Med. 1982;72(4):60-2.
  25. Evangelista AT, Beilstein HR. Laboratory diagnosis of gonorrhea. Washington DC: American Society for Microbiology; 1993. p. 78-89.
  26. Ohlemeyer CL, Hornberger LL, Lynch DA, Swierkosz EM. Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy. J Adolesc Health. 1998;22(3):205-8.
  27. Thayer JD, Martin JE Jr. Improved medium selective for cultivation of N. gonorrhoeae and N. meningitidis. Public Health Rep. 1966;81(6):559-62.
  28. Samra Z, Soffer Y. IgA antichlamydia antibodies as a diagnostic tool for monitoring of active chlamydial infection. Eur J Epidemiol. 1992;8(6):882-4.
  29. Johnson PC, Farnie MA. Testing for syphilis. Dermatol Clin. 1994;12(1):9-17.
  30. World Health Organization (WHO). WHO special program research in human reproduction. Program for provision of matched assay reagents for immunoassay of hormones, immunometrics. London: WHO; 1999. Enzymeimmunoassay technique; p. 4-42.
  31. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol. 1994;234:279-93.
  32. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem. 1985;57(7):1170-3.
  33. Rabiu KA, Adewunmi AA, Akinlusi FM, Akinola OI. Female reproductive tract infections: understandings and care seeking behaviour among women of reproductive age in Lagos, Nigeria. BMC Womens Health. 2010;10:8.
  34. Sekoni AO, Odukoya OO, Onajole AT, Odeyemi KA. Sexually transmitted infections: prevalence, knowledge and treatment practices among female sex workers in a cosmopolitan city in Nigeria. Afr J Reprod Health. 2013;17(1):94-102.
  35. Omoregie R, Egbe CA, Igbarumah IO, Ogefere H, Okorie E. Prevalence and etiologic agents of female reproductive tract infection among in-patients and out-patients of a tertiary hospital in Benin city, Nigeria. N Am J Med Sci. 2010;2(10):473-7.
  36. Agrawal T, Vats V, Wallace PK, Salhan S, Mittal A. Cervical cytokine responses in women with primary or recurrent chlamydial infection. J Interferon Cytokine Res. 2007;27(3):221-6.
  37. Bedaiwy M, Shahin AY, AbulHassan AM, Goldberg JM, Sharma RK, Agarwal A, et al. Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles. Reprod Biomed Online. 2007;15(3):321-5.
  38. Pajovic SB, Saicic ZS. Modulation of antioxidant enzyme activities by sexual steroid hormones. Physiol Res. 2008;57(6):801-11.
  39. de Carvalho LF, Abrao MS, Biscotti C, Sharma R, Agarwal A, Falcone T. Mapping histological levels of 8-hydroxy-2'-deoxyguanosine in female reproductive organs. J Mol Histol. 2013;44(1):111-6.
  40. Paszkowski T, Traub AI, Robinson SY, McMaster D. Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta. 1995;236(2):173-80.
  41. Azenabor AA, Mahony JB. Generation of reactive oxygen species and formation and membrane lipid peroxides in cells infected with Chlamydia trachomatis. Int J Infect Dis. 2000;4(1):46-50.
  42. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;17(10):1195-214.
  43. Rusconi B, Greub G. Chlamydiales and the innate immune response: friend or foe? FEMS Immunol Med Microbiol. 2011;61(3):231-44.
  44. Nsonwu-Anyanwu AC, Charles-Davies MA, Oni AA, Taiwo VO, Bello FA. Chlamydial infection, plasma peroxidation and obesity in tubal infertility. Ann Ib Postgrad Med. 2011;9(2):83-8.
  45. Wira C, Fahey J, Wallace P, Yeaman G. Effect of the menstrual cycle on immunological parameters in the human female reproductive tract. J Acquir Immune Defic Syndr. 2005;38 Suppl 1:S34-6.
  46. Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521-74.
  47. Borekci B, Ingec M, Kumtepe Y, Karaca M, Koc F, Salman S, et al. Effect of estrogen, progesterone, LH, and FSH on oxidant and antioxidant parameters in rat uterine tissue. Int J Fertil Steril. 2009;3(3):119-28.
  48. Aten RF, Duarte KM, Behrman HR. Regulation of ovarian antioxidant vitamins, reduced glutathione, and lipid peroxidation by luteinizing hormone and prostaglandin F2 alpha. Biol Reprod. 1992;46(3):401-7.
  49. Kawaguchi S, Sakumoto R, Okuda K. Induction of the expressions of antioxidant enzymes by luteinizing hormone in the bovine corpus luteum. J Reprod Dev. 2013;59(3):219-24.
  50. Wang Y, Sharma RK, Falcone T, Goldberg J, Agarwal A. Importance of reactive oxygen species in the peritoneal fluid of women with endometriosis or idiopathic infertility. Fertil Steril. 1997;68(5):826-30.